Inventiva (IVA) Current Assets (2018 - 2025)
Inventiva's (IVA) quarterly Current Assets came in at $284.6 million in Q4 2025, up 138.82% year-on-year from $119.2 million in Q4 2024, and down 99.85% quarter-over-quarter from $195.6 billion in Q2 2025.
Inventiva (IVA) Current Assets (2018 - 2025) Analysis & Trends
Inventiva's Current Assets history runs 8 years deep, the most recent figure standing at $284.6 million for Q4 2025.
- On a quarterly basis, Current Assets rose 138.82% year-over-year to $284.6 million in Q4 2025; TTM through Dec 2025 was $284.6 million, a 138.82% increase from a year earlier, with the FY2025 full-year figure at $284.6 million, up 138.82% from the prior year.
- Current Assets retreated to $284.6 million in Q4 2025 per IVA's latest filing, from $195.6 billion in the prior quarter.
- Across five years, Current Assets topped out at $195.6 billion in Q2 2025 and bottomed at $2.2 million in Q2 2024.
- The 5-year median for Current Assets is $132.2 million (2021), against an average of $30.3 billion.
- Across the five-year window, Current Assets sank 52.23% in 2023 and soared 9014717.25% in 2025, its largest moves.
- Year by year, Current Assets stood at $132.2 million in 2021, then declined by 17.91% to $108.5 million in 2022, then sank by 52.23% to $51.8 million in 2023, then soared by 129.82% to $119.2 million in 2024, then soared by 138.82% to $284.6 million in 2025.
- Per Business Quant, the three latest IVA Current Assets figures stand at $284.6 million (Q4 2025), $195.6 billion (Q2 2025), and $119.2 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 284.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 284.57 Mn |
| Jun 30, 2025 | 195.62 Bn |
| Dec 31, 2024 | 119.16 Mn |
| Jun 30, 2024 | 2.17 Mn |
| Dec 31, 2023 | 51.85 Mn |
| Dec 31, 2022 | 108.54 Mn |
| Jun 30, 2022 | 106.63 Bn |
| Dec 31, 2021 | 132.22 Mn |
| Jun 30, 2021 | 132.26 Mn |
| Mar 31, 2021 | 151.28 Mn |
| Dec 31, 2020 | 158.57 Mn |
| Jun 30, 2020 | 66.27 Mn |
| Dec 31, 2019 | 54.10 Mn |
| Dec 31, 2018 | 81.76 Mn |